1. FAERS subgroup disproportionality scores versus PRAC subgroup risk

   Clinical study 20 May 2023 Pages: 1 - 1

2. FDA updates Boxed Warning and prescribing information for stimulants

   News item 20 May 2023 Pages: 2 - 2

3. Griseofulvin-related SCARs

   News item 20 May 2023 Pages: 3 - 3

4. Live attenuated dengue vaccine Qdenga: common AEs

   News item 20 May 2023 Pages: 4 - 4

5. PRAC meeting highlights May 2023: hydroxyprogesterone review initiated

   News item 20 May 2023 Pages: 5 - 5

6. Reduction in pack size of paracetamol products in Australia

   News item 20 May 2023 Pages: 6 - 6

7. Associations between COVID-19 vaccination and menstruation disorders "weak and inconsistent"

   Clinical study 20 May 2023 Pages: 7 - 7

8. Cannabidiol-related liver injury

   Clinical study 20 May 2023 Pages: 8 - 8

9. CAR-T cell therapy-related acute renal failure

   Clinical study 20 May 2023 Pages: 9 - 9

10. Immune checkpoint inhibitor-related psychiatric disorders

    Clinical study 20 May 2023 Pages: 10 - 10

11. Nirmatrelvir+ritonavir-related AEs in patients with COVID-19 infections

    Clinical study 20 May 2023 Pages: 11 - 11

12. Prevalence of potential DDIs in hospital cardiology unit

    Clinical study 20 May 2023 Pages: 12 - 12

13. Other adverse reaction research

    News item 20 May 2023 Pages: 13 - 13

14. Aciclovir/prednisolone

    Case report 20 May 2023 Pages: 14 - 14

15. Aclarubicin and antineoplastics

    Case report 20 May 2023 Pages: 15 - 15

16. Ad26.COV2-S/AZD-1222/elasomeran

    Case report 20 May 2023 Pages: 16 - 16

17. Ad26.cov2-s/elasomeran

    Case report 20 May 2023 Pages: 17 - 17

18. Adalimumab

    Case report 20 May 2023 Pages: 18 - 18

19. Adefovir-dipivoxil

    Case report 20 May 2023 Pages: 19 - 19

20. Afatinib

    Case report 20 May 2023 Pages: 20 - 20

21. Aflibercept/bevacizumab

    Case report 20 May 2023 Pages: 21 - 21

22. Ajmaline

    Case report 20 May 2023 Pages: 22 - 22

23. Albumin-human/midodrine/octreotide

    Case report 20 May 2023 Pages: 23 - 23

24. Alemtuzumab/anakinra

    Case report 20 May 2023 Pages: 24 - 24

25. Alendronic-acid

    Case report 20 May 2023 Pages: 25 - 25

26. Aluminium/deferoxamine/sodium chloride

    Case report 20 May 2023 Pages: 26 - 26

27. Amantadine

    Case report 20 May 2023 Pages: 27 - 27

28. Amiodarone

    Case report 20 May 2023 Pages: 28 - 28

29. Amiodarone/lidocaine/metoprolol/propranolol

    Case report 20 May 2023 Pages: 29 - 29

30. Amiodarone/moxifloxacin

    Case report 20 May 2023 Pages: 30 - 30

31. Amiodarone/procainamide

    Case report 20 May 2023 Pages: 31 - 31

32. Amlodipine overdose

    Case report 20 May 2023 Pages: 32 - 32

33. Amoxicillin/clavulanic-acid

    Case report 20 May 2023 Pages: 33 - 33

34. Amoxicillin/clavulanic-acid/dipyrone

    Case report 20 May 2023 Pages: 34 - 34

35. Amoxicillin/esomeprazole/furazolidone

    Case report 20 May 2023 Pages: 35 - 35

36. Amphotericin-B

    Case report 20 May 2023 Pages: 36 - 36

37. Anagrelide

    Case report 20 May 2023 Pages: 37 - 37

38. Andexanet-alfa

    Case report 20 May 2023 Pages: 38 - 38

39. Anti-cd19-car-transduced-t-cells/car-bcma-t-cell

    Case report 20 May 2023 Pages: 39 - 39

40. Antibacterials

    Case report 20 May 2023 Pages: 40 - 40

41. Antibacterials/paraffin/steroids

    Case report 20 May 2023 Pages: 41 - 41

42. Anticoagulants/aspirin

    Case report 20 May 2023 Pages: 42 - 42

43. Antiepileptic drugs

    Case report 20 May 2023 Pages: 43 - 43

44. Antiepileptic-drugs

    Case report 20 May 2023 Pages: 44 - 44

45. Antineoplastic drugs

    Case report 20 May 2023 Pages: 45 - 45

46. Antineoplastics

    Case report 20 May 2023 Pages: 46 - 46

47. Antineoplastics

    Case report 20 May 2023 Pages: 47 - 47

48. Antineoplastics

    Case report 20 May 2023 Pages: 48 - 48

49. Antineoplastics

    Case report 20 May 2023 Pages: 49 - 49

50. Antineoplastics

    Case report 20 May 2023 Pages: 50 - 50